Antonia Pierobon, Francesco Zanatta, Nicolò Granata, Ekaterina Nissanova, Jacek Polański, Wojciech Tański, Giovanna Callegari, Angelo Caporotondi, Chiara Ferretti, Polańska Beata Jankowska-
{"title":"合并高血压和 2 型糖尿病的老年患者坚持治疗的自我效能的社会心理和行为相关性。","authors":"Antonia Pierobon, Francesco Zanatta, Nicolò Granata, Ekaterina Nissanova, Jacek Polański, Wojciech Tański, Giovanna Callegari, Angelo Caporotondi, Chiara Ferretti, Polańska Beata Jankowska-","doi":"10.5114/hpr/159284","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Adhering to clinical prescriptions is known to protect against the effects of uncontrolled hypertension and of acute and chronic cardiovascular diseases, including diabetes. Contextually, positive associations between self-care behaviors and psychological constructs, such as self-efficacy, are widely acknowledged in the literature. However, still little is known about the psychological factors underlying the patient's self-efficacy. This study aimed to investigate the psychosocial and behavioral correlates of self-efficacy related to treatment adherence in older patients with comorbid hypertension and type 2 diabetes mellitus.</p><p><strong>Participants and procedure: </strong>Italian and Polish patients (≥ 65 years; <i>N</i> = 180) consecutively responded to self-report questionnaires measuring psychosocial (i.e., beliefs about medicines, perceived physician's communication effectiveness, medication-specific social support, self-efficacy) and behavioral factors (i.e., pharmacological adherence, medications refill adherence, intentional non-adherence) related to treatment adherence. Between-group comparisons and regression analyses were performed.</p><p><strong>Results: </strong>Fisher's least significant difference (LSD) test showed significant differences between the Italian and Polish groups in all questionnaires (<i>p</i> < .01) with the Italian patients reporting more satisfactory scores. Younger age (β = .08, <i>p</i> = .045), female gender (β = 1.03, <i>p</i> = .042), higher medication refills adherence (β = -.07, <i>p</i> = .024), lower intentional non-adherence (β = -.03, <i>p</i> = .009), positive beliefs about medications (β = .13, <i>p</i> < .001), better quality of communication with the physician (β = .09, <i>p</i> < .001), and stronger perceived medication-specific social support (β = .06, <i>p</i> = .001) were significantly associated with self-efficacy related to treatment adherence.</p><p><strong>Conclusions: </strong>Future research and interventions should leverage psychosocial and behavioral factors to address self-efficacy contributing to enhancing adherence to clinical prescriptions.</p>","PeriodicalId":93913,"journal":{"name":"Bone","volume":"24 1","pages":"188-199"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670798/pdf/","citationCount":"0","resultStr":"{\"title\":\"Psychosocial and behavioral correlates of self-efficacy in treatment adherence in older patients with comorbid hypertension and type 2 diabetes.\",\"authors\":\"Antonia Pierobon, Francesco Zanatta, Nicolò Granata, Ekaterina Nissanova, Jacek Polański, Wojciech Tański, Giovanna Callegari, Angelo Caporotondi, Chiara Ferretti, Polańska Beata Jankowska-\",\"doi\":\"10.5114/hpr/159284\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Adhering to clinical prescriptions is known to protect against the effects of uncontrolled hypertension and of acute and chronic cardiovascular diseases, including diabetes. Contextually, positive associations between self-care behaviors and psychological constructs, such as self-efficacy, are widely acknowledged in the literature. However, still little is known about the psychological factors underlying the patient's self-efficacy. This study aimed to investigate the psychosocial and behavioral correlates of self-efficacy related to treatment adherence in older patients with comorbid hypertension and type 2 diabetes mellitus.</p><p><strong>Participants and procedure: </strong>Italian and Polish patients (≥ 65 years; <i>N</i> = 180) consecutively responded to self-report questionnaires measuring psychosocial (i.e., beliefs about medicines, perceived physician's communication effectiveness, medication-specific social support, self-efficacy) and behavioral factors (i.e., pharmacological adherence, medications refill adherence, intentional non-adherence) related to treatment adherence. Between-group comparisons and regression analyses were performed.</p><p><strong>Results: </strong>Fisher's least significant difference (LSD) test showed significant differences between the Italian and Polish groups in all questionnaires (<i>p</i> < .01) with the Italian patients reporting more satisfactory scores. Younger age (β = .08, <i>p</i> = .045), female gender (β = 1.03, <i>p</i> = .042), higher medication refills adherence (β = -.07, <i>p</i> = .024), lower intentional non-adherence (β = -.03, <i>p</i> = .009), positive beliefs about medications (β = .13, <i>p</i> < .001), better quality of communication with the physician (β = .09, <i>p</i> < .001), and stronger perceived medication-specific social support (β = .06, <i>p</i> = .001) were significantly associated with self-efficacy related to treatment adherence.</p><p><strong>Conclusions: </strong>Future research and interventions should leverage psychosocial and behavioral factors to address self-efficacy contributing to enhancing adherence to clinical prescriptions.</p>\",\"PeriodicalId\":93913,\"journal\":{\"name\":\"Bone\",\"volume\":\"24 1\",\"pages\":\"188-199\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670798/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bone\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/hpr/159284\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/hpr/159284","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Psychosocial and behavioral correlates of self-efficacy in treatment adherence in older patients with comorbid hypertension and type 2 diabetes.
Background: Adhering to clinical prescriptions is known to protect against the effects of uncontrolled hypertension and of acute and chronic cardiovascular diseases, including diabetes. Contextually, positive associations between self-care behaviors and psychological constructs, such as self-efficacy, are widely acknowledged in the literature. However, still little is known about the psychological factors underlying the patient's self-efficacy. This study aimed to investigate the psychosocial and behavioral correlates of self-efficacy related to treatment adherence in older patients with comorbid hypertension and type 2 diabetes mellitus.
Participants and procedure: Italian and Polish patients (≥ 65 years; N = 180) consecutively responded to self-report questionnaires measuring psychosocial (i.e., beliefs about medicines, perceived physician's communication effectiveness, medication-specific social support, self-efficacy) and behavioral factors (i.e., pharmacological adherence, medications refill adherence, intentional non-adherence) related to treatment adherence. Between-group comparisons and regression analyses were performed.
Results: Fisher's least significant difference (LSD) test showed significant differences between the Italian and Polish groups in all questionnaires (p < .01) with the Italian patients reporting more satisfactory scores. Younger age (β = .08, p = .045), female gender (β = 1.03, p = .042), higher medication refills adherence (β = -.07, p = .024), lower intentional non-adherence (β = -.03, p = .009), positive beliefs about medications (β = .13, p < .001), better quality of communication with the physician (β = .09, p < .001), and stronger perceived medication-specific social support (β = .06, p = .001) were significantly associated with self-efficacy related to treatment adherence.
Conclusions: Future research and interventions should leverage psychosocial and behavioral factors to address self-efficacy contributing to enhancing adherence to clinical prescriptions.